Coloplate 50mg Injection
Marketer
Cytocare Formulations Pvt Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Coloplate 50mg Injection
Oncoplate 50mg Injection combats colorectal cancer by inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only under medical guidance. Common side effects include nausea, tiredness, vomiting, and diarrhea. This medication can suppress blood cell production, increasing infection risk. Severe allergic reactions (indicated by mouth sores, rash, itching, or breathing difficulties) necessitate immediate medical attention. Regular blood tests monitoring blood cell counts, along with heart, liver, and uric acid levels, are essential. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, including antibiotics, to your doctor, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding. Due to potential infertility in males, sperm banking should be discussed with your physician beforehand. Post-injection dizziness may impair driving ability.
Uses of Coloplate 50mg Injection
Colorectal cancer
Major Benefits of Coloplate 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Coloplate 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Coloplate 50mg Injection:
This medication will be administered by your physician or their associate; self-medication is strongly discouraged.
How Coloplate 50mg Injection works:
Oncoplate 50mg injection is a chemotherapeutic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) of malignant cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Coloplate 50mg Injection may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Coloplate 50mg Injection during pregnancy is contraindicated due to established fetal risks. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards to the fetus. Seek medical advice before use.
Breast feedingUNSAFE
Administration of Coloplate 50mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingUNSAFE
Administering Coloplate 50mg Injection or Oxaliplatin may induce adverse reactions, including dizziness, nausea, vomiting, and neurological symptoms impacting gait. These effects could impair driving ability.
KidneyCAUTION
For individuals with severely impaired kidney function, administering Coloplate 50mg Injection requires careful consideration and potential dose modification. Consult a physician for guidance. Data regarding Coloplate 50mg Injection use in such patients is limited. No dosage alteration is suggested for those with mildly or moderately compromised kidney function.
LiverCAUTION
Individuals with hepatic impairment should use 50mg Coloplate injections cautiously. Dosage modification for this injection may be necessary. Physician consultation is advised.
What if you forget to take Coloplate 50mg Injection :
Omitting a scheduled dose of the injectable medication, Coloplate 50mg, necessitates contacting your physician.
Facts to Know About Coloplate 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavioral Class | Platinum-based Anticancer Agents |
3,018 People bought this recently